CBFB and granular cell tumor: However, because EOC and GCT are different in cells of origin, pathophysiology, and response to chemotherapy, a better understanding of the role for RUNX/CBFβ in tumorigenesis of GCT is warranted to determine whether targeting RUNX/CBFβ could be a potential therapeutic strategy to treat GCT.